Cover Image
QR Code

Digital Therapies for Amblyopia.

Amblyopia is a developmental visual disorder with consequences beyond reduced visual acuity, affecting stereoacuity, contrast sensitivity, oculomotor function, and eye-hand coordination. While patching remains the longstanding standard of care, adherence challenges and its inherently monocular appro...

Full description

Published in:Optometry & Visual Performance Vol. 14; no. 2; pp. 154 - 159
Main Author: Kin, Man
Format: Journal Article
Published: Optometric Extension Program Jun2026
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195202345&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195202345
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23253479
        HOOW
      jtl: Optometry & Visual Performance
      issn: 23253479
      maglogo: N
    pubinfo:
      dt: Jun2026
      vid: 14
      iid: 2
      pid: 46881
      pub: Optometric Extension Program
      place: Lutherville Timonium, Maryland
    artinfo:
      ui:
        195202345
        195202345
      ppf: 154
      ppct: 5
      formats:
      tig:
        atl: Digital Therapies for Amblyopia.
      aug:
        au: Kin, Man
        affil: Clinical Affiliate Faculty/Preceptor, Nova Southeastern University College of Optometry
      sug:
        subj:
          Amblyopia Therapy
          Digital Health Utilization
          Visual Acuity
          Treatment Outcomes
          Individualized Medicine
      ab: Amblyopia is a developmental visual disorder with consequences beyond reduced visual acuity, affecting stereoacuity, contrast sensitivity, oculomotor function, and eye-hand coordination. While patching remains the longstanding standard of care, adherence challenges and its inherently monocular approach have driven the development of a new generation of digital and perceptual learning-based therapies. This article reviews five clinically relevant technologies--Luminopia, CureSight, AmblyoPlay, Bynocs, and RevitalVision--examining their mechanisms of action, treatment protocols, and supporting clinical evidence. Collectively, these platforms represent a meaningful expansion of the amblyopia treatment toolbox, offering patients and clinicians options that are engaging, home-based, and in many cases, capable of addressing the binocular and cortical deficits that patching alone does not target. Selecting the right tool requires an understanding of each platform's unique delivery, its evidence base, and the patient's individual visual profile.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N